In a retrospective review of data from the National Poison Data System, the safety of physostigmine in pediatric patients was assessed. What was the median age of the patients who received physostigmine?
The median age of the groups that received physostigmine was 15 years.
Huber S, Avera R, Penfound S, Overberg A, Nañagas K. Safety of Physostigmine for Pediatric Antimuscarinic Poisoning. J Med Toxicol. 2024 Jan 24. doi: 10.1007/s13181-024-00988-0. Epub ahead of print. PMID: 38265619.
Contributed by Brittany Allison, PharmD, MBA, PGY2 Emergency Medicine Pharmacy Resident, AdventHealth Orlando on behalf of the Florida Poison Information Center Netwtork
Posted in Question Of The Day